Peter-Paul M

Aug 13, 2024 | link.springer.com | Van Den Hout |van der Meer |Peter-Paul M |Gerardus P. J

AbstractA left ventricular assist device (LVAD) is a life-saving but intensive therapy for patients with end-stage heart failure. We evaluated the healthcare consumption in a cohort of LVAD patients in our centre over 6 years. All patients with a primary LVAD implantation at the University Medical Centre Utrecht in Utrecht, the Netherlands from 2016 through 2021 were included in this analysis.